Vijaya Diagnostic Centre Limited, founded in 1981 by Dr. S. Surendranath Reddy, stands as India's largest comprehensive diagnostic network. The company proudly operates 140+ state-of-the-art diagnostic centers across 20+ cities, serving over 80 million customers throughout its four-decade journey in healthcare diagnostics.
Originally incorporated as Vijaya Diagnostic Centre Private Limited on 05 June 2002, the company subsequently converted to a Public Limited Company with its name changed to Vijaya Diagnostic Centre Limited on 26 March 2021. The company went public through an IPO worth Rs 1,895.04 crore in September 2021, with shares listed on both BSE and NSE on 14 September 2021.
Vijaya Diagnostic Centre operates through the Diagnostic Services segment, providing a comprehensive range of diagnostic services spanning pathological investigations, basic and high-end radiology, nuclear medicine, and related healthcare services. The company's extensive service portfolio includes clinical pathology, microbiology, hematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, computerized tomography (CT) scan, magnetic resonance imaging (MRI) scan, ultrasound, x-ray, cardiology, gastroenterology, nuclear medicine, PET CT, and MRI-3T.
The company holds the distinction of being the largest integrated diagnostic chain in South India and was among the first in the region to offer PET-CT scans. The organization's strength lies in its team of over 200 dedicated professionals, including seasoned radiologists, committed pathologists, and skilled microbiologists, whose expertise drives the company's mission to provide quality diagnostic services.
In the organized diagnostic segment, Vijaya Diagnostic competes with established players like Apollo, Metropolis, Dr Lal PathLabs Ltd, Thyrocare Technologies Ltd, and Agilus Diagnostics, a unit of Fortis Healthcare. The company's strategic expansion was marked by its acquisition of 100% equity stake in P H Diagnostic Centre Private Limited in December 2023, making it a wholly owned subsidiary and marking the company's entry into the Western India market, particularly in Pune.
Recent expansion initiatives include the opening of an advanced center in Barasat, Kolkata, featuring the city's first 3T MRI, showcasing the company's commitment to bringing cutting-edge diagnostic technology to new markets.
As of July 7, 2025, the company's market capitalization stands at Rs 10,479.22 crore, reflecting its significant position in the healthcare diagnostics sector. The stock has a 52-week high of Rs 1,275 and a 52-week low of Rs 740.
- P/E Ratio: 73.24
- P/B Ratio: 15.88
- Dividend Yield: 0.20%
#### FY 2025 Performance
For the full year ended March 2025, net profit rose 20.41% to Rs 143.08 crore compared to Rs 118.83 crore in the previous year. Sales increased by 24.38% to Rs 681.39 crore from Rs 547.81 crore in FY 2024.
#### Q4 FY 2025 Results
In the quarter ended March 2025, net profit grew 3.56% to Rs 34.64 crore compared to Rs 33.45 crore in the same quarter of the previous year. Sales rose 11.62% to Rs 173.24 crore from Rs 155.21 crore in Q4 FY 2024.
#### Q3 FY 2025 Performance
The company reported strong Q3 FY 2025 results with net profit jumping 36.02% to Rs 35.16 crore and revenue rising 27% to Rs 169 crore, driven by increased patient volumes and service expansions.
Promoter holding in the company stands at 53.91% as of December 2024, down from 54.06% as of March 2024. The company is led by Chairman & Executive Director Sura Surendranath Reddy, who has been instrumental in the organization's growth since its founding.
Vijaya Diagnostic Centre has been honored as one of the "10 Most Trusted Brands of the Year 2019" by Business Sight Magazine for its valuable contribution as a leading brand with excellent magnification, business practices, and professional dedication. The company has been recognized for Service Excellence in Integrated Diagnostics Care at Times Health Excellence Awards 2023.
The company was awarded as the "Fastest growing brand (Pride of nation)" by Asia One magazine at the Indo-UAE Business & Social Forum in Emirates Dubai in 2019. Vijaya Diagnostic Centre also won the 'Company of the Year' award under the healthcare category at the Dare2Dream Awards 2021, organized by TV9 Network and SAP India.
Vijaya Diagnostic Centre Ltd belongs to the Health Care sector and Hospitals & Diagnostic Centres sub-sector. Over the last three years, the company's share price has moved up by 116.30% on BSE, demonstrating strong long-term performance in the healthcare diagnostics space.
The company continues to focus on expanding its diagnostic network while maintaining its leadership position in South India's organized diagnostic market, making it a significant player in India's growing healthcare infrastructure sector.
